STOCK TITAN

BZAM Ltd. - $BZAMF STOCK NEWS

Welcome to our dedicated page for BZAM Ltd. news (Ticker: $BZAMF), a resource for investors and traders seeking the latest updates and insights on BZAM Ltd. stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BZAM Ltd.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BZAM Ltd.'s position in the market.

News
Rhea-AI Summary
BZAM grants options to purchase 85,000 Common Shares to employees at an exercise price of $0.16 per share. Options vest on anniversaries and expire in 5 years.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.48%
Tags
none
-
Rhea-AI Summary
BZAM Ltd. reports Q2 2023 financial results with gross revenues of $30.0 million, up 89% from Q2 2022, and net revenues of $19.3 million, up 66% from Q2 2022. The Company captured 4.4% market share in Q2 2023, ranking as the 7th largest producer in Canada. However, the Company recorded a net loss of $65.5 million due to non-cash impairment charges. The Company achieved EU-EMP certification for international distribution. The sale of the Midway, BC facility and the Maple Ridge, BC facility is expected to produce approximately $7 million in gross proceeds. The Company is focused on cost reduction and revenue expansion to improve cash flows and strengthen its balance sheet.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.18%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.81%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.15%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.74%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.14%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.2%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.5%
Tags
none
BZAM Ltd.

OTC:BZAMF

BZAMF Rankings

BZAMF Stock Data

9.10M
50.44M
113.74%
0.02%
Medicinal and Botanical Manufacturing
Manufacturing
Link
United States of America
Mississauga